Work

Phase 1/2 Trial of a Novel CDK Inhibitor Dinaciclib (SCH727965) in Patients with Relapsed Multiple Myeloma Demonstrates Encouraging Single Agent Activity

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.76.76

Authors: Shaji K. Kumar, Betsy R. LaPlant, Wee Joo Chng, Jeffrey A. Zonder, Natalie Callander, Vivek Roy, Briant Furth, Charles Erlichman, Keith Stewart

Institutions: Mayo Clinic, National University Health System, The Barbara Ann Karmanos Cancer Institute, University of Wisconsin–Madison, Mayo Clinic Comprehensive Cancer Center (Florida), Mayo Clinic in Arizona

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979335942

FWCI: 1.538

Cites:

Cited by: 9

Related to: 10